B Gaborit1, I Abdesselam2, F Kober3, A Jacquier4, O Ronsin5, O Emungania6, N Lesavre7, M-C Alessi8, J C Martin8, M Bernard3, A Dutour1. 1. 1] Department of Endocrinology, Metabolic Diseases and Nutrition, CHU Nord, Marseille, France [2] Inserm U1062, Inra U1260, Faculté de Médecine, Marseille, France [3] Aix Marseille Université, Marseille, France. 2. 1] Inserm U1062, Inra U1260, Faculté de Médecine, Marseille, France [2] Aix Marseille Université, Marseille, France [3] Aix Marseille Université CNRS, Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR 7339, Marseille, France. 3. 1] Aix Marseille Université, Marseille, France [2] Aix Marseille Université CNRS, Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR 7339, Marseille, France. 4. 1] Aix Marseille Université, Marseille, France [2] Aix Marseille Université CNRS, Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR 7339, Marseille, France [3] Department of Radiology, CHU Timone, Marseille, France. 5. Department of Endocrinology, Metabolic Diseases and Nutrition, CHU Nord, Marseille, France. 6. Department of Digestive Surgery, CHU Nord, Marseille, France. 7. 1] Centre d'investigation Clinique (CIC), CHU Nord, Marseille, France [2] Gastroenterology Department, CHU Nord, Marseille, France. 8. 1] Inserm U1062, Inra U1260, Faculté de Médecine, Marseille, France [2] Aix Marseille Université, Marseille, France.
Abstract
OBJECTIVES: Recent literature suggests that ectopic fat deposition in the pancreas may contribute to endocrine and exocrine organ dysfunction, such as type 2 diabetes (T2D), pancreatitis or pancreatic cancer. The aim of this study was to determine factors associated with pancreatic triglyceride content (PTGC), and to investigate the impact of bariatric surgery on ectopic fat pads, pancreatic fat (PTGC) and hepatic fat (HTGC). SUBJECTS: In all, 45 subjects (13 lean, 13 obese nondiabetics and 19 T2D, matched for age and gender) underwent 1H-magnetic resonance spectroscopy, computed tomography of the visceral abdominal fat, metabolic and lipidomic analysis, including insulin-resistance homeostasis model assessment (HOMA-IR), insulin-secretion homeostasis model assessment (HOMA-B) and plasma fatty-acid composition. Twenty obese subjects were reassessed 6 months after the bariatric surgery. RESULTS: PTGC was significantly higher in type 2 diabetic subjects (23.8±3.2%) compared with obese (14.0±3.3; P=0.03) and lean subjects (7.5±0.9%; P=0.0002). PTGC remained significantly associated with T2D after adjusting for age and sex (β=0.47; P=0.004) or even after adjusting for waist circumference, triglycerides and HOMA-IR (β=0.32; P=0.04). T2D, C18:1n-9 (oleic acid), uric acid, triglycerides and plasminogen activator inhibitor-1 were the five more important parameters involved in PTGC prediction (explained 80% of PTGC variance). Bariatric surgery induced a huge reduction of both HTGC (-51.2±7.9%) and PTGC (-43.8±7.0%) reaching lean levels, whereas body mass index remained greatly elevated. An improvement of insulin resistance HOMA-IR and no change in HOMA-B were observed after bariatric surgery. The PTGC or HTGC losses were not correlated, suggesting tissue-specific mobilization of these ectopic fat stores. CONCLUSION: Pancreatic fat increased with T2D and drastically decreased after the bariatric surgery. This suggests that decreased PTGC may contribute to improved beta cell function seen after the bariatric surgery. Further, long-term interventional studies are warranted to examine this hypothesis and to determine the degree to which ectopic fat mobilization may mediate the improvement in endocrine and exocrine pancreatic functions.
OBJECTIVES: Recent literature suggests that ectopic fat deposition in the pancreas may contribute to endocrine and exocrine organ dysfunction, such as type 2 diabetes (T2D), pancreatitis or pancreatic cancer. The aim of this study was to determine factors associated with pancreatictriglyceride content (PTGC), and to investigate the impact of bariatric surgery on ectopic fat pads, pancreatic fat (PTGC) and hepatic fat (HTGC). SUBJECTS: In all, 45 subjects (13 lean, 13 obese nondiabetics and 19 T2D, matched for age and gender) underwent 1H-magnetic resonance spectroscopy, computed tomography of the visceral abdominal fat, metabolic and lipidomic analysis, including insulin-resistance homeostasis model assessment (HOMA-IR), insulin-secretion homeostasis model assessment (HOMA-B) and plasma fatty-acid composition. Twenty obese subjects were reassessed 6 months after the bariatric surgery. RESULTS: PTGC was significantly higher in type 2 diabetic subjects (23.8±3.2%) compared with obese (14.0±3.3; P=0.03) and lean subjects (7.5±0.9%; P=0.0002). PTGC remained significantly associated with T2D after adjusting for age and sex (β=0.47; P=0.004) or even after adjusting for waist circumference, triglycerides and HOMA-IR (β=0.32; P=0.04). T2D, C18:1n-9 (oleic acid), uric acid, triglycerides and plasminogen activator inhibitor-1 were the five more important parameters involved in PTGC prediction (explained 80% of PTGC variance). Bariatric surgery induced a huge reduction of both HTGC (-51.2±7.9%) and PTGC (-43.8±7.0%) reaching lean levels, whereas body mass index remained greatly elevated. An improvement of insulin resistance HOMA-IR and no change in HOMA-B were observed after bariatric surgery. The PTGC or HTGC losses were not correlated, suggesting tissue-specific mobilization of these ectopic fat stores. CONCLUSION:Pancreatic fat increased with T2D and drastically decreased after the bariatric surgery. This suggests that decreased PTGC may contribute to improved beta cell function seen after the bariatric surgery. Further, long-term interventional studies are warranted to examine this hypothesis and to determine the degree to which ectopic fat mobilization may mediate the improvement in endocrine and exocrine pancreatic functions.
Authors: Sarah Navina; Chathur Acharya; James P DeLany; Lidiya S Orlichenko; Catherine J Baty; Sruti S Shiva; Chandra Durgampudi; Jenny M Karlsson; Kenneth Lee; Kyongtae T Bae; Alessandro Furlan; Jaideep Behari; Shiguang Liu; Teresa McHale; Larry Nichols; Georgios Ioannis Papachristou; Dhiraj Yadav; Vijay P Singh Journal: Sci Transl Med Date: 2011-11-02 Impact factor: 17.956
Authors: B Gaborit; F Kober; A Jacquier; P J Moro; T Cuisset; S Boullu; F Dadoun; M-C Alessi; P Morange; K Clément; M Bernard; A Dutour Journal: Int J Obes (Lond) Date: 2011-07-05 Impact factor: 5.095
Authors: Alpa V Patel; Carmen Rodriguez; Leslie Bernstein; Ann Chao; Michael J Thun; Eugenia E Calle Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-02 Impact factor: 4.254
Authors: N J van der Zijl; G H Goossens; C C M Moors; D H van Raalte; M H A Muskiet; P J W Pouwels; E E Blaak; M Diamant Journal: J Clin Endocrinol Metab Date: 2010-11-17 Impact factor: 5.958
Authors: Katherine E Pinnick; Stephan C Collins; Constantine Londos; Dominique Gauguier; Anne Clark; Barbara A Fielding Journal: Obesity (Silver Spring) Date: 2008-01-17 Impact factor: 5.002
Authors: May-Yun Wang; Paul Grayburn; Shuyuan Chen; Mariella Ravazzola; Lelio Orci; Roger H Unger Journal: Proc Natl Acad Sci U S A Date: 2008-04-14 Impact factor: 11.205
Authors: Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Moor; Philipp Madörin; Andreas Schötzau; Diana Nabers; Stefan Borgwardt; Christoph Beglinger; Oliver Bieri; Bettina K Wölnerhanssen Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: Tawfik Khoury; Akwi W Asombang; Tyler M Berzin; Jonah Cohen; Douglas K Pleskow; Meir Mizrahi Journal: Dig Dis Sci Date: 2017-08-08 Impact factor: 3.199
Authors: Kathleen M Hertzer; Mu Xu; Aune Moro; David W Dawson; Lin Du; Gang Li; Hui-Hua Chang; Alexander P Stark; Xiaoman Jung; Oscar Joe Hines; Guido Eibl Journal: Pancreas Date: 2016-03 Impact factor: 3.327